Table 3.
Disorder | Mechanism |
---|---|
Gout
|
Alcohol reduced renal urate excretion in lactic acidemia; Several antihypertensives interfere with renal tubular ion transport; Immunosuppressants (i.e. cyclosporine), reduce renal clearance of serum urate. Impaired kidney function. Mutation of gene for uromodulin. Mutations of genes for polycystins 1 (PC1) and 2 (PC2). |
| |
Cardiovascular disorders (8,64,69)
|
Endothelial dysfunction, oxidative stress, inhibition of NO-synthesis. |
| |
Hypertension (8,64,69,72,89) | Endothelial disfunction (60); Activation of renin-angiotensin system (55); Impaired glomerular filtration rate (63); Inhibition of NO-synthesis. |
| |
Chronic kidney disease (8) | Increased monocyte chemoattractant protein (MCP-1) in cultured vascular smooth muscle cells and human proximal tubular epithelial cells. |
| |
Metabolic syndrome and its components (79)
|
Increased intracellular adenosine (uric acid precursor a derivative of higher AMP concentrations due to increased synthesis of fatty acid-acyl-CoA in peripheral tissues. |
| |
Therapy of cancer | Purine derivatives |